BCPT02
BCPT02 (Page 64) is a drug-linker conjugate used for the synthesis of bispecific antibody drug conjugates (ADC) [1].
Product Specifications
CAS Number
[3025473-38-2]
UNSPSC
12352005
Target
Drug-Linker Conjugates for ADC
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C(CCOCC(COCCC(NC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)=O)(COCCC(NC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)=O)NC(CC[C@H](NC(CCCCCN1C(C=CC1=O)=O)=O)C(N[C@@H](C(C)C)C(N[C@@H](C)C(NC2=CC=C3C4=C2OCCC4=C(CN5C6=O)C(C5=CC([C@@](CC)7O)=C6COC7=O)=N3)=O)=O)=O)=O)NC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O
Molecular Formula
C76H111N11O33
Molecular Weight
1706.75
References & Citations
[1]Yangyang Xu, et al. ANTI-TPBG/MUC1 ANTIBODIES AND USES THEREOF CLAIM OF PRIORITY. WO2025180383 A1
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
